New microfluidic-based sampling procedure for overcoming the hematocrit problem associated with dried blood spot analysis.

Details

Serval ID
serval:BIB_BED19111B5DF
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
New microfluidic-based sampling procedure for overcoming the hematocrit problem associated with dried blood spot analysis.
Journal
Analytical Chemistry
Author(s)
Leuthold L.A., Heudi O., Déglon J., Raccuglia M., Augsburger M., Picard F., Kretz O., Thomas A.
ISSN
1520-6882 (Electronic)
ISSN-L
0003-2700
Publication state
Published
Issued date
2015
Peer-reviewed
Oui
Volume
87
Number
4
Pages
2068-2071
Language
english
Notes
Publication types: Journal Article Publication Status: ppublish
Abstract
Hematocrit (Hct) is one of the most critical issues associated with the bioanalytical methods used for dried blood spot (DBS) sample analysis. Because Hct determines the viscosity of blood, it may affect the spreading of blood onto the filter paper. Hence, accurate quantitative data can only be obtained if the size of the paper filter extracted contains a fixed blood volume. We describe for the first time a microfluidic-based sampling procedure to enable accurate blood volume collection on commercially available DBS cards. The system allows the collection of a controlled volume of blood (e.g., 5 or 10 μL) within several seconds. Reproducibility of the sampling volume was examined in vivo on capillary blood by quantifying caffeine and paraxanthine on 5 different extracted DBS spots at two different time points and in vitro with a test compound, Mavoglurant, on 10 different spots at two Hct levels. Entire spots were extracted. In addition, the accuracy and precision (n = 3) data for the Mavoglurant quantitation in blood with Hct levels between 26% and 62% were evaluated. The interspot precision data were below 9.0%, which was equivalent to that of a manually spotted volume with a pipet. No Hct effect was observed in the quantitative results obtained for Hct levels from 26% to 62%. These data indicate that our microfluidic-based sampling procedure is accurate and precise and that the analysis of Mavoglurant is not affected by the Hct values. This provides a simple procedure for DBS sampling with a fixed volume of capillary blood, which could eliminate the recurrent Hct issue linked to DBS sample analysis.
Pubmed
Web of science
Create date
26/01/2015 8:25
Last modification date
20/08/2019 15:33
Usage data